Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Clinical trial NCT07100600 · RECRUITING
Trial details
- NCT number
- NCT07100600
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-30
- Primary completion
- 2030-07-30
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.